StemCyte International, Ltd. (TPEX:4178)

StemCyte International Statistics

Total Valuation

TPEX:4178 has a market cap or net worth of TWD 5.14 billion. The enterprise value is 3.27 billion.

Market Cap	5.14B
Enterprise Value	3.27B

Important Dates

The next estimated earnings date is Wednesday, April 29, 2026.

Earnings Date	Apr 29, 2026
Ex-Dividend Date	n/a

Share Statistics

TPEX:4178 has 192.48 million shares outstanding. The number of shares has increased by 6.53% in one year.

Current Share Class	192.48M
Shares Outstanding	192.48M
Shares Change (YoY)	+6.53%
Shares Change (QoQ)	-4.01%
Owned by Insiders (%)	10.17%
Owned by Institutions (%)	9.43%
Float	158.85M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	13.93
PB Ratio	2.96
P/TBV Ratio	2.97
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-18.47
EV / Sales	8.85
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-59.48

Financial Position

The company has a current ratio of 10.42, with a Debt / Equity ratio of 0.13.

Current Ratio	10.42
Quick Ratio	8.74
Debt / Equity	0.13
Debt / EBITDA	n/a
Debt / FCF	-3.98
Interest Coverage	-17.14

Financial Efficiency

Return on equity (ROE) is -9.59% and return on invested capital (ROIC) is -6.77%.

Return on Equity (ROE)	-9.59%
Return on Assets (ROA)	-4.36%
Return on Invested Capital (ROIC)	-6.77%
Return on Capital Employed (ROCE)	-7.93%
Weighted Average Cost of Capital (WACC)	n/a
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.11
Inventory Turnover	0.58

Taxes

In the past 12 months, TPEX:4178 has paid 3.67 million in taxes.

Income Tax	3.67M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -16.04% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-16.04%
50-Day Moving Average	28.79
200-Day Moving Average	26.04
Relative Strength Index (RSI)	47.75
Average Volume (20 Days)	201,321

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TPEX:4178 had revenue of TWD 368.91 million and -176.81 million in losses. Loss per share was -0.92.

Revenue	368.91M
Gross Profit	126.82M
Operating Income	-225.17M
Pretax Income	-173.14M
Net Income	-176.81M
EBITDA	-196.93M
EBIT	-225.17M
Loss Per Share	-0.92

Balance Sheet

The company has 2.09 billion in cash and 218.43 million in debt, with a net cash position of 1.87 billion or 9.73 per share.

Cash & Cash Equivalents	2.09B
Total Debt	218.43M
Net Cash	1.87B
Net Cash Per Share	9.73
Equity (Book Value)	1.74B
Book Value Per Share	9.03
Working Capital	2.36B

Cash Flow

In the last 12 months, operating cash flow was -52.43 million and capital expenditures -2.48 million, giving a free cash flow of -54.90 million.

Operating Cash Flow	-52.43M
Capital Expenditures	-2.48M
Depreciation & Amortization	61.55M
Net Borrowing	-26.85M
Free Cash Flow	-54.90M
FCF Per Share	-0.29

Margins

Gross margin is 34.38%, with operating and profit margins of -61.04% and -47.93%.

Gross Margin	34.38%
Operating Margin	-61.04%
Pretax Margin	-46.93%
Profit Margin	-47.93%
EBITDA Margin	-53.38%
EBIT Margin	-61.04%
FCF Margin	n/a

Dividends & Yields

TPEX:4178 does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-6.53%
Shareholder Yield	-6.53%
Earnings Yield	-3.44%
FCF Yield	-1.07%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TPEX:4178 has an Altman Z-Score of 2.54 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.54
Piotroski F-Score	1